Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

IBSscreen - The New Home Test for IBS to Reduce the Anxiety of Not Knowing


News provided by

Ferring Pharmaceuticals

18 Apr, 2016, 07:05 GMT

Share this article

Share toX

Share this article

Share toX

This image opens in the lightbox
A pack of IBSscreen together with its contents (PRNewsFoto/Ferring Pharmaceuticals)
This image opens in the lightbox
The IBSscreen Test Strip (PRNewsFoto/Ferring Pharmaceuticals)

SHEFFIELD, England, April 18, 2016 /PRNewswire/ --

A recent survey of 219 people who treat themselves for IBS has found that 80% of them feel some anxiety associated with the very common condition - over 52% were 'very' or 'extremely anxious' about it[1] .

The same survey also found that the large majority (78%) of GPs are sympathetic to the plight of their IBS patients. Despite that, it may require anywhere between 1 and 5 visits before other conditions that give rise to the same symptoms, notably Crohn's Disease or Colitis, can be excluded and a formal diagnosis is given[2].

For that reason, Ferring UK today launches IBSscreen, a rapid test to help people with chronic abdominal symptoms - including Irritable Bowel Syndrome - determine with confidence whether their symptoms really are due to IBS. That way, IBSscreen can help set someone more at ease or set them on the right course of treatment.

IBSscreen, which is as quick and as convenient as a pregnancy test, can be conducted in the privacy of the sufferer's home and takes only 10 minutes to do. That, together with a short questionnaire that is included in each pack or online at http://www.IBSscreen.co.uk, should inform the sufferer what steps may be needed to effectively manage the symptoms.

IBSscreen is as accurate as the tests for IBD run in hospital and the test is already in use by some NHS Clinical Commissioning Groups. Therefore, the user can have confidence in the result. As Dr Nick Read, Chair of Trustees and Medical Adviser of The IBS Network says, "With this test, people can be reassured that they don't have chronic inflammation of the bowels".

IBS - The hidden distress of 11 million people 

Irritable Bowel Syndrome affects nearly 10-20% of the UK population[3] - between 6 and 13 million people in all. It usually presents as pain in the abdomen and bloating[4]. Other symptoms include altered bowel habit (alternating constipation and diarrhoea), gas and abdominal cramps[4]. It is also associated with other symptoms such as lethargy, headaches and urinary frequency[5]. So, IBS can affect the whole person, not just the gut.

In addition, 50-60% of people with IBS can frequently suffer from anxiety and depression[6]. Although this has not been shown to worsen the perception of the pain, it is an additional strain on the sufferer[6]. Dr Read says that: "Many IBS patients suffer in silence with their condition. This can cause feelings of isolation which will deepen their distress."

IBS itself is not life-threatening - even though it is a legitimate disorder as opposed to being 'nothing wrong'[6] - and having the condition does not mean that it will lead to anything more serious. The symptoms are caused when the muscles in the gut spasm at the wrong time and this manifests itself as acute, excruciating pain.

There are numerous treatments available for IBS, many of which are available on prescription including laxatives, fibre or bulking agents and antispasmodic drugs. In addition, sufferers can find relief through changes in diet as well as other techniques such as relaxation therapy to reduce stress[3].

IBSscreen - How the home test works 

IBSscreen detects the presence of a chemical called calprotectin. This chemical, which is found in your stools, is only present when there is inflammation in the gut[1]. Its presence means that you could have a condition like Inflammatory Bowel Disease (e.g. Crohn's Disease or Ulcerative Colitis), whilst its absence - which is 50 times more likely numerically in the UK population[4],[7] - means that you might have a 'functional' bowel disorder such as IBS or chronic constipation.

Each pack contains the following items:

  • A small vial containing a reagent and a sample probe
  • A test strip
  • A paper stool catcher
  • A short symptom questionnaire
  • Instructions for use

     (Photo: http://photos.prnewswire.com/prnh/20160413/354756 )

IBSscreen can be used the next time you visit the toilet.

  • Sling the paper stool catcher across the toilet seat
  • Remove the sample probe from the vial and insert it in three different locations of the stool (this may seem unpleasant but it is very quick and shouldn't even need the wearing of gloves!)
  • Replace the probe in the vial - the collar on the vial will remove any excess sample material
  • Shake the vial with the reagent
  • Break the seal at the other end of the vial and put three drops only on the test strip
  • Within 10 minutes you should see a red line develop - this is a confirmation line that the test is working
  • If you see a second line, then IBSscreen has detected the calprotectin and you should see a doctor for further investigation
  • If no second line appears, then you can be assured that you have a 'functional' disorder such as IBS or constipation and you can relax that it is readily treatable

     (Photo: http://photos.prnewswire.com/prnh/20160413/354755 )

About Ferring Pharmaceuticals 

Headquartered in Switzerland, Ferring Pharmaceuticals is a research-driven, specialty biopharmaceutical group active in global markets.

The company identifies, develops and markets innovative products in the areas of reproductive health, urology, gastroenterology, endocrinology and orthopaedics. Ferring has its own operating subsidiaries in nearly 60 countries and markets its products in 110 countries.

To learn more about Ferring or its products please visit http://www.ferring.co.uk

References 

  1. Ferring Survey of People with IBS, Data on File: March 2016
  2. Hungin A et al, Aliment Pharmacol Ther 17: 643-650
  3. Faecal calprotectin diagnostic tests for inflammatory disease of the bowel; NICE Diagnostics Guidance 11 (Oct 2013)
  4. IBS in adults: diagnosis and management; NICE Clinical Guidelines 61 (Feb 2008)
  5. Whorwell P et al, Gut. 1986 Jan; 27(1):37-40
  6. Whorwell P, JR Soc Med. 1989 Oct;82(10):613-614
  7. Mowat C et al, Gut. 2011 May;60(5):571-607

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.